Chuanshan Zhang et al. found that TIGIT might also be a potential therapeutic target for HAE as liver weight, lesion weight, lesion area, and confluent lesion numbers were significantly lower in TIGIT blocked mice as compared with control mice (Zhang et al., 2020). Here, TIGIT is linked to hereditary angioedema.